Literature DB >> 1483053

Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy, with special reference to mental ability.

S V Hodgson1, S Abbs, S Clark, A Manzur, J Z Heckmatt, V Dubowitz, M Bobrow.   

Abstract

We report the results of screening for molecular deletions in 164 boys with DMD and BMD and correlation of deletions with clinical features. A deletion was detected in 100 cases (61%) by Southern blot hybridization analysis with cDNA probes. Thirty-eight different deletions and two duplications were identified. All deletions except one (deletion of exons 48-53) found in males with DMD disrupted the translational reading frame of the gene; however, six deletions in boys with BMD were out of frame. The same deletion in different individuals was found to occur with or without mental impairment, and many different deletions were associated with mental retardation. We were able to ascertain a series of boys [from this study and a previous one (Hodgson S V, Hart K, Abbs S, et al. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet 1989; 26: 682-693)] without significant mental retardation who had deletions which, when combined, covered the whole region of the gene in which deletions are commonly found, and within which region individual deletions can be associated with mental retardation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1483053     DOI: 10.1016/0960-8966(92)90059-f

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  8 in total

Review 1.  Dystrophin Dp71: the smallest but multifunctional product of the Duchenne muscular dystrophy gene.

Authors:  Ramin Tadayoni; Alvaro Rendon; L E Soria-Jasso; Bulmaro Cisneros
Journal:  Mol Neurobiol       Date:  2011-11-22       Impact factor: 5.590

2.  Deletions in the 5' region of dystrophin and resulting phenotypes.

Authors:  F Muntoni; P Gobbi; C Sewry; T Sherratt; J Taylor; S K Sandhu; S Abbs; R Roberts; S V Hodgson; M Bobrow
Journal:  J Med Genet       Date:  1994-11       Impact factor: 6.318

3.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

4.  Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.

Authors:  L V Nicholson; M A Johnson; K M Bushby; D Gardner-Medwin; A Curtis; I B Ginjaar; J T den Dunnen; J L Welch; T J Butler; E Bakker
Journal:  J Med Genet       Date:  1993-09       Impact factor: 6.318

5.  Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy.

Authors:  Peter J Taylor; Grant A Betts; Sarah Maroulis; Christian Gilissen; Robyn L Pedersen; David R Mowat; Heather M Johnston; Michael F Buckley
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

6.  Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment?

Authors:  Stefano Vicari; Giorgia Piccini; Eugenio Mercuri; Roberta Battini; Daniela Chieffo; Sara Bulgheroni; Chiara Pecini; Simona Lucibello; Sara Lenzi; Federica Moriconi; Marika Pane; Adele D'Amico; Guja Astrea; Giovanni Baranello; Daria Riva; Giovanni Cioni; Paolo Alfieri
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

Review 7.  Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy.

Authors:  Michael Naidoo; Karen Anthony
Journal:  Mol Neurobiol       Date:  2019-12-13       Impact factor: 5.590

Review 8.  Towards Central Nervous System Involvement in Adults with Hereditary Myopathies.

Authors:  Jens Reimann; Cornelia Kornblum
Journal:  J Neuromuscul Dis       Date:  2020
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.